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In cell-mediated cytotexic reactions involving thymus-dependent (T) lymphocytes pre- 
sensitized against virus-infected (1-5) or chemically modified (6-8) cells, the ability of the 
immunocompetent cell(s) to respond against the foreign substance depends most likely on 
a complex system of receptors capable of recognizing both the major histocompatibility 
(H-2) antigens and the "classical" antigen. Such a "two-step" interaction between killer 
cell and target cell apparently is a  necessary prerequisite for efficient cytolysis to be 
effected. Similarly, additional studies (9-12)  have now shown that cytotoxic reactivity 
against non-H-2 alloantigens in mouse also belong to this category of reactions. In all 
these systems, susceptibility of target cells to lysis has required sharing of H-2-associated 
serologically defined (SD)' antigens by the sensitizing and subsequent target cells. This 
phenomenon, referred to as H-2-restricted cytolysis, has resulted in the development of 
two major groups of hypotheses: the "altered-self' or H-2 modification hypothesis (3, 7, 9), 
and the dual recognition or intimacy hypothesis (13). The altered-self hypothesis states 
that antigen capable of inducing cytotoxic T lymphocytes (CTLs) do so through modifica- 
tion of H-2 SD molecules on the same cell and thereby create the necessary point for 
cytotoxic attack. The dual recognition hypothesis, on the other hand, argues that a CTL 
is  equipped  with  at  least  two  distinct receptors,  one specific for the  relevant major 
histocompatibility SD molecule, and the second specific for the "classical" antigen (e.g., 
the virus-specific or chemical-modification determinant). As yet, however, no conclusive 
experiment exists  which  decides between these  two  groups  of hypotheses as  to how 
immunocompetent T lymphocytes recognize and respond to immunogens. 
In the present report we show how different in vitro culture conditions can 
yield completely different patterns of T-cell reactivity against  non-H-2-associ- 
ated gene products in mouse. Our primary aim has been to determine what role 
non-H-2  alloantigens  play in initiation  and restimulation  of mixed leukocyte 
culture (MLC) and cell-mediated lympholysis (CML) reactions. Results indicate 
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that either H-2-restricted or non-H-2 antigen-specific reactions can be generated 
in vitro depending only on the primary culture conditions: heterologous serum 
induces H-2-restricted reactions, while homologous serum permits development 
of specific  anti-non-H-2 alloantigen reactions. These findings have important 
bearing on theoretical discussions of how proliferative and cytotoxic T lympho- 
cytes recognize self-H-2 structures, as well as carry a warning as to how H-2- 
restricted reactions may be generated in vitro, and perhaps in vivo, without 
actual intention by the investigator. 
Materials and Methods 
Mice.  Inbred strains of mice used in this study and maintained in this laboratory are A.AL, 
A.BY, A.TL, B10.A, B10.AKM, B10.BR, B10.M, B10.RIII(71NS), B10.S, B10.S(7R), CBA/H, CBA/ 
J, C3H/HeJ, C57BL/6Bom, and C57BL/10Sn. Strain C57BL/10Sn and its congenic resistant part- 
ner strains were established from breeding pairs generously provided by Dr. F. H. Bach (Immuno- 
biology Research Center, University of Wisconsin, Madison, Wis.). Strains A.AL and A.TL were 
kindly  provided by  Dr.  D.  C.  Shreffler (Department of Genetics,  Washington University,  St. 
Louis, Mo.). Both male and female mice were utilized and ranged in age from 4 to 20 wk. 
Culture Medium.  The serum-free medium as described by Click et al. (14) and Heber-Katz et 
al. (15) was supplemented with either 0.5% normal mouse serum according to the protocol of Peck 
and Click (16), or with 2.5% fetal bovine serum (FBS). The mouse serum was homologous with the 
responding strain and pooled from a  minimum of six animals. FBS was purchased from GIBCO- 
BIO-CULT,  Glasglow, Scotland or Flow Laboratories Svenska AB, Solna, Sweden. Six different 
batches of sera were used in this study. 
MLC Combinations.  Primary MLCs were performed in tissue culture flasks (no. 3013,  Falcon 
Plastics,  Div.  of BioQuest,  Oxnard,  Calif.).  Each flask contained 20-25  x  106 responding cells 
cultured  with  an  equal  number of X-irradiated  (1,500-2,000  R)  stimulating cells  in  12  ml  of 
medium. At various times of culture the cells were dispersed from the bottom of the flask with a 
Pasteur pipette; 0.2 ml of this cell suspension was removed to microtiter plate wells for radiolabel- 
ing. 
Secondary  MLCs  were  performed  in  microtiter  plate  cultures  according  to  the  procedures 
described by Peck and Bach (17). Cultures consisted of 0.05 x  106 or 0.075 ×  106 responding cells (T- 
cell blasts) cultured with 0.5  x  106 X-irradiated stimulating cells. 
At appropriate times of culture, as indicated in the text and figure legends, 0.8 ~Ci tritiated 
thymidine (3H-TdR) (Amersham, London, England) in a volume of 0.02 ml was added to each well 
for 4 h. Cells were filtered through glass-fiber filters using a multiple-sample harvester (Skatron; 
Flow  Laboratories,  Oslo,  Norway)  and  total  3H-TdR  incorporation  was  determined  by  liquid 
scintillation  procedures.  Data  are  expressed  in  counts  per  minute  of the  mean  of triplicate 
cultures. In general, standard deviations of primary MLC's are less than 10% of the means and 
those of the secondary MLCs are less than 5%. 
Preparation of Responding  T Lymphocytes.  The responding cells in primary MLC were pre- 
pared by passage of whole spleen cell suspensions whose contaminating erythrocytes had been 
lysed in a 0.84% NH4C1 treatment through Ig-anti-Ig glass bead columns, according to the protocol 
of Wigzell  et  al.  (18).  This  procedure  removes  Ig-bearing B  cells.  After  passage  through the 
columns, the nonadherent cells are washed twice in phosphate-buffered saline (PBS) and resus- 
pended to a  density of 100  x  106 cells/ml. The resulting cell population can be shown to be >98% 
theta antigen-bearing T cells and <0.5% Ig-bearing B cells. 
Separation of MLC-Reactive T Blast Cells from Primary Cultures.  The MLC-reactive T lym- 
phocytes were separated as T  blast cells from the nonresponsive population using 1 g  velocity 
sedimentation procedures as described by Miller and Phillips (19) and Andersson and H~iyry (20). 
Primary MLC cells were collected from the culture flasks following maximum 3H-TdR incorpora- 
tion, resuspended in PBS supplemented with 4% FBS,  then layered over a  linear 15-30% FBS 
gradient. The cells were permitted to fall through the gradient for 3-4 h. Fractions of 12 ml each 
were collected and microscopically examined for numbers of blast and nonblast cells. Only those 
fractions containing >95% blast cells were kept. After two to four washes with PBS, the resulting 
pooled T-lymphocyte blast cell suspension was divided into two aliquots: the first was immediately 804  RESPONSES  OF  T  LYMPHOCYTES  TO  NON-H-2  ALLOANTIGENS 
dispensed  to microtiter plate wells and restimulated with appropriate  stimulating cell popula- 
tions, while the second was placed in tissue culture flasks (nos. 3013 or 3024; Falcon Plastics, Div. 
of BioQuest) for 3 days before restimulation.  This 3-day incubation permitted the blast cells to 
revert to small lymphocytes. 
CML Assay.  CML was performed according to procedures detailed elsewhere  (21) and is a 
modification of the techniques described by Alter et al.  (22). The effector cells were generated in 
secondary MLC, after restimulation periods of 48 or 60 h. The secondary primed lymphocytes were 
collected from the mixed cultures, pooled, centrifuged, and washed twice in serum-flee medium or 
medium supplemented with 2.5%  FBS. 
LPS-stimulated spleen cells were used as the target cells. Approximately 48 h before the CML 
assay,  appropriate  target cell cultures containing  10.0  ×  10  ~ spleen cells in 5.0 ml serum-free 
medium or medium supplemented with FBS were established in culture dishes (no. 3002; Falcon 
Plastics,  Div. of BioQuest).  Target cells were incubated 2 h  then stimulated with 25-50  izg/ml 
lipopolysaccharide (LPS) (prepared by Dr. G. M~ller, Laboratory of Immunobiology, Karolinska 
Institute, Stockholm, Sweden). At time of assay the target cells were collected, centrifuged, resus- 
pended in 0.4 ml of supernate removed from the centrifuged cells, and labeled for 1 h with 250-400 
tzCi Na~51CrO4. The labeled cells were washed three times in medium. Trinitrophenyl (TNP)-con- 
jugated target cells were prepared according to the procedures of Shearer (6). 
Cell destruction  was performed in round-bettomed  Sterilin microtiter plates  (Sterilin Ltd., 
Teddington,  Middlesex, England) at various effector cell numbers plus 1.0  x  104 labeled target 
cells. Cell destruction proceeded 4 h, al~er which time the plates were centrifuged, the supernate 
collected, and the quantity of released 5~Cr determined.  Percent cytotoxicity is expressed as 
[slCr released ~exp,  -  5~Cr released~s~nta,~o~] 
×  100. 
[  51Cr released~maxi  ....  --  ~ICr release~spont  .....  ~] 
Results 
Development  of Specific  Memory  against  Mls  Locus  Products  in  Cultures 
Supplemented  with Mouse Serum.  Splenic T lymphocytes from B10.BR mice 
(H-2 k,  Mls b) devoid of Ig-bearing  B  cells and  stimulated  with whole spleen 
cells from CBA/J mice (H-2 k, Mls d) exhibit strong primary MLC activation in 
cultures  supplemented  with homologous serum,  as shown in Fig.  1 A.  Since 
both strains possess the H-2 k haplotype, MLC activation is believed to result 
primarily from different allelic products of the Mls locus (23, 24).  On day 5 of 
primary culture (i.e., 24 h after maximum 3H-TdR incorporation) B10.BR anti- 
CBA/J blast cells were separated from the nonreactive cells on a  1 g  velocity 
sedimentation  gradient,  as  described  in  the  Materials  and  Methods.  The 
isolated T-cell blasts were re-established as the responding cell population and 
stimulated with spleen cells from mice possessing various genetic differences. 
Results, presented in Fig.  1 B, clearly show a  specific, secondary-like reactiv- 
ity by B10.BR anti-CBA/J blast cells against CBA/J spleen cells. No restimu- 
lation is observed when cells from B10.BR (the responding strain),  CBA/H (H- 
2 k,  Mlsb-similar  to B10.BR), A.AL  (H-2 at, Mls¢'),  or B10.RIII(71NS)  (H-2 r, 
Mls b) are used as the stimulating  populations.  In addition,  C3H/HeJ (H-2 k, 
Mls"), B10.AKM (H-2 m, Mlsb), and C57BL/10 (1-1-2  b, Mls b) also failed to cause 
strong reactivation,  although the data is not included here. 
A highly specific anti-CBA/J pattern of MLC reactivation is also observed if 
before restimulation  the B10.BR anti-CBA/J blast cells are first permitted to 
revert to small lymphocyte-like cells (determined by morphological examina- 
tion in a  microscope) through incubation in tissue culture flasks for 3 days in 
the  absence  of stimulating  cells  (Fig.  1 C).  Moreover,  the  reverted  B10.BR AMMON  B.  PECK,  LEIF  C.  ANDERSSON,  AND  HANS  WIGZELL  805 
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Fro.  1.  Specific memory responses  against Mls locus products in cultures supplemented 
with  mouse  serum.  (A)  Kinetics  of primary  MLC  activation  of B10.BR  T  lymphocytes 
stimulated with CBA/J spleen cells. Cultures were carried out in tissue culture flasks and 
the arrow indicates time at which the activated cells were collected for secondary MLC. (B) 
Kinetics of secondary MLC activation of purified B10.BR anfi-CBA/J blast cells stimulated 
with CBA/J (0--0),  A.AL (/x--A), B10.RIII(71NS)  (A--&), CBA/H (x---x), and B10.BR 
(O--O) spleen cells. MLC were carried out in microtiter plates. (C) 3H-TdR incorporation of 
B10.BR anti-CBA/J cells stimulated with spleen cells from indicated strains after reversion 
of blast cells to small lymphocyte-like cells. Activation was measured at 60 h of culture. All 
cultures  contained  medium  supplemented  with  0.5%  normal  mouse  serum.  Stimulating 
cells were inactivated by X irradiation (1,750 R). 3H-TdR (0.8  ~Ci/well) was added to each 
culture 4 h before termination of MLC at times indicated. 
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anti-CBA/J cells elicit a distinctly secondary-like response against CBA/J cells 
with maximum 3H-TdR incorporation occurring around 60 h of culture (unpub- 
lished  observation).  All  other  combinations  examined,  including  B10.BR, 
CBA/H, C3H/HeJ, B10.AKM,  B10.D2/n (H-2 ~, Mlsb), B10.S(7R) (H-2 th, Mlsb), 
and C57BL/10,  fail to cause strong reactivation,  although a  small,  but repro- 
ducible,  stimulation occurs with C3H/HeJ and C57BL/10.  Thus, B10.BR anti- 
CBA/J T lymphocytes generated in homologous mouse serum are strongly, and 
specifically,  restimulated  by cells of the primary stimulating strain,  CBA/J, 
and exhibit a  specific memory response. 
Similarly, a specific anti-CBA/J secondary response is obtained if, instead of 
B10.BR,  CBA/H T lymphocytes are used as the responding population and the 
primary  MLC  contains  homologous mouse  serum  (data  not  included  here). 
B10.BR and CBA/H,  both possessing H-2 k and Mls b, are mutually nonrespon- 
sive toward one another in MLC. 
Development of  H-2-Restricted Responses after Activation by Mls Locus Prod- 
ucts in Cultures Supplemented with Heterologous Serum.  The experiments of 
the previous section were repeated using identical culture conditions except in 
place of homologous mouse serum, FBS at a concentration of 2.5% was used to 806  RESPONSES  OF  T  LYMPHOCYTES  TO  NON-H-2  ALLOANTIGENS 
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Fio.  2.  H-2-restricted secondary responses of cells primed in vitro against the Mls locus in 
cultures  supplemented with  FBS. (A) Kinetics  of primary MLC activation  of CBA/H T 
lymphocytes stimulated  with  CBA/J  spleen  cells. Cultures  were carried  out in  tissue 
culture flasks. Arrow indicates time at which the activated cells were collected for second- 
ary MLC. (B) Kinetics of secondary MLC activation of purified CBA/H anti-CBA/J blast 
cells stimulated  with CBA/J (©--©), CBA/H (x---x), B10.BR (@--0),  B10.AKM (AMA), 
and B10.S (A--A) spleen cells. MLC were performed in  microtiter  plates.  (C) 3H-TdR 
incorporation of CBA/H anti-CBA/J cells stimulated with spleen cells from various strains 
of mice after reversion of the blast cells to small lymphocyte-like cells. MLC activation was 
measured at 60 h of culture.  All reactions were performed in medium supplemented with 
2.5% FBS. Stimulating  cells were inactivated by X irradiation  (1,650 R). 3H-TdR (0.8 ~Ci) 
was added to each culture 4 h before termination  of MLC at times indicated. 
supplement  the  medium.  Splenic  T  lymphocytes from  CBA/H  mice  (H-2 k, 
Mls b) stimulated by whole spleen cells from CBA/J mice (H-2 k, Mls d) exhibit a 
strong primary MLC response under these conditions, as depicted in Fig. 2 A. 
Again, this MLC activation is considered to be primarily against the Mls locus 
product(s). The CBA/H anti-CBA/J blast cells were isolated after peak 3H-TdR 
incorporation in primary MLC on a  1 g  velocity sedimentation gradient and re- 
established  as  responding  cells  in  microcultures.  Again  spleen  cells  from 
various mouse strains were used as stimulating cells and the kinetics of MLC 
proliferation  were  followed.  Results  are  presented  in  Fig.  2 B.  X-irradiated 
CBA/J  cells,  syngeneic  with  the  specific  primary  MLC  activator,  induces 
strong secondary-like reactivation with  maximum aH-TdR incorporation oc- 
curring 48 h after restimulation. However, strong secondary responses are not 
restricted to CBA/J cells:  MLC reactivation is induced by cells from CBA/H 
(syngeneic with  the  responding population,  i.e.,  self),  B10.BR  (H-2 k,  Mlsb), 
and  B10.AKM  (H-2 m,  Mlsb).  In  contrast,  B10.S  (H-2",  Mlsb),  a  strain  not 
carrying the H-2 k haplotype,  induces little  if any reactivation of the CBA/H 
anti-CBA/J T  blast cells.  Since B10.AKM is  an H-2 recombinant strain  pos- 
sessing part of the H-2 k haplotype,  it  appears  that CBA/H anti-CBA/J cells AMMON  B.  PECK,  LEIF  C.  ANDERSSON~  AND  HANS  WIGZELL  807 
generated in cultures containing heterologous serum respond against any cell- 
type carrying  a  part of or the whole 1-1-2  ~ haplotype,  irrespective of the Mls 
locus allele. 
When  the  CBA/H  anti-CBA/J  T  blasts  are  permitted  to  revert  to  small 
lymphocyte-like cells before restimulation,  the  pattern  of reactivation  (Fig. 
2 C)  is  similar  to  that  observed  when  blast  cells  are  directly  restimulated. 
Stimulation with CBA/J cells elicits the strongest response, but again strong 
MLC reactivity is induced by cells carrying the 1-1-2  k haplotype (e.g., CBA/H, 
B10.BR,  and  C3H/HeJ) or even a  part  of I"t-2 k  [e.g.,  B10.A,  B10.AKM,  and 
B10.HTT  (tt-2 tt,  Mlsb)].  Once  more,  only  slight,  if  any,  MLC  activity  is 
observed  with  strains  possessing  non-H-2k-derived  haplotypes  [e.g.,  B10.M 
(1-1-2  f, Mlsb), B10.S(7R), and B10.S]. Thus, CBA/H anti-CBA/J cells generated 
in heterologous serum exhibit H-2-restricted,  secondary-like  responses after 
priming against Mls locus antigen. 
Data  in  Fig.  2 C  also  suggests  that  H-2-restricted  MLC  activation  can  be 
determined by genes located solely in H-2 I.  Two of the stimulating  strains- 
B10.HTT, whose 1-1-2 derivation is ssskkd, 2 and B10.S(7R), whose derivation is 
sssssd-presumably  possess genetic  differences  only  at  1-1-2 I-C  and H-2  S. 
Despite this,  B10.HTT cells stimulate the CBA/H anti-CBA/J blasts, whereas 
B10.S(7R)  cells do not. Assuming that the 1-1-2 S  region products are inactive in 
MLC activation (25, 26), the H-2 restriction must result from 1-1-2 I-C subregion 
identity between B10.HTT and  CBA/J.  In  any event,  the H-2  K  and 1-1-2 D 
regions appear irrelevant for H-2-restricted MLC responses against B10.HTT. It 
should  also  be  noted  that  B10.A  (kkkddd),  which  shares  1-1-2 I-A  and  I-B 
subregions with CBA/J, and B10.AKM (kkkkkq), which shares the whole H-2 I 
region with CBA/J, induce progressively stronger MLC responses, thus suggest- 
ing a  correlation between I  region sharing-and  strength of reactivation. 
B10.BR anti-CBA/J  T  blast cell responses have  also been examined  in the 
presence  of FBS.  A  similar H-2k-restricted  MLC  activity occurs  (data  is  not 
presented here to avoid duplication),  thereby indicating that Mls locus specific 
and H-2-restricted responses are not strain-dependent phenomena. 
H-2-Restricted  MLC  Activation:  Dependence  on  Primary  Culture  Condi- 
tions.  Mls  locus-primed  T  lymphocytes can  exhibit  either  an  H-2-restricted 
response or a  specific anti-Mls locus memory response.  This difference appar- 
ently  depends  only  on  whether  the  primary  MLC  contains  heterologous  or 
homologous  serum,  respectively.  Of interest,  then,  was  to  test  if the  H-2- 
restricted  secondary MLC  activation  results  from specific modification of H-2 
products by FBS. In order for this phenomenon to be due to H-2 modification, 
two requirements must be fulfilled: (a) the responding cells must be generated 
in  primary  cultures  containing  FBS,  and  (b)  secondary  cultures  must  also 
contain FBS so as to permit an identical modification of secondary stimulating 
cells. 
Splenic B10.BR T  lymphocytes were stimulated with CBA/H spleen cells in 
primary MLC containing either homologous mouse serum or FBS. Strong MLC 
2 Denotes the K, I-A, I-B, I-C, S, and D regions of H-2 and from which haplotype they were 
derived. 8O8 
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FIa.  3.  Dependence on primary MLC for development of anti-Mls locus or H-2-restricted 
responses. B10.BR  T lymphocytes were stimulated with CBA/J spleen cells in primary MLC 
containing either 0.5% normal mouse serum (NMS) or 2.5% FBS. At 108 h of culture each 
activated population of B10.BR anti-CBA/J blast cells was collected and divided into two 
aliquots. Each aliquot was re-established as responding cells in secondary MLC: one set in 
medium containing mouse serum,  the other set in medium containing FBS. The B10.BR 
anti-CBA/J blast cells were stimulated with X-irradiated (2,000 R) spleen cells from various 
s  strains and  H-TdR incorporation was measured at 48 h of culture, after a 4 h pulse with 0.8 
/~Ci/culture. 
proliferation occurred in both systems, as shown in Fig..3.  Both sets of B10.BR 
anti-CBA/J blasts were then isolated by 1 g  velocity sedimentation procedures 
and re-established as the responding populations in mixed cultures containing 
either  mouse serum or FBS.  The B10.BR anti-CBA/J blast cells generated  in 
homologous serum  exhibited  a  highly specific secondary anti-CBA/J response 
whether the secondary cultures contained homologous serum or FBS (Fig. 3). In 
a  similar manner, B10.BR anti-CBA/J cells generated in FBS exhibited strong 
H-2k-restricted  secondary  responsiveness  (including  anti-self  reactivity)  in 
either FBS or mouse serum containing cultures. Thus, specificity of reactivity in 
restimulation  of B10.BR anti-CBA/J blast cells  is determined by the  primary 
culture conditions and is independent of secondary culture conditions. 
Heterologous  Serum-Dependent  H-2-Restricted  Cytolysis  after  Secondary 
MLC Activation  of T  Lymphocytes Primed In  Vitro against Mls Locus Prod- 
ucts.  Results of the previous sections indicate that H-2-restricted MLC respon- 
siveness develops after priming ofT cells against the Mls locus product(s) in the 
presence  of FBS.  We  therefore  wished  to  examine  the  cytolytic  activity  of 
secondary MLC-activated T  lymphocytes to determine,  first,  if effector T  cells 
can be generated by this protocol, and second, if so, will the subsequent cytotox- AMMON  B.  PECK,  LEIF  C.  ANDERSSON,  AND  HANS  WIGZELL  809 
icity be Mls locus specific or H-2 restricted. One point of interest is that CTLs 
are normally not generated in primary MLC against Mls locus products (21, 24, 
27). 
Splenic T lymphocytes from either B10.BR mice or CBA/H mice were primed 
in vitro with whole spleen cells from CBA/J mice. The B10.BR anti-CBA/J and 
CBA/H anti-CBA/J blast cells were isolated 1 day after peak MLC activation on 
1 g  velocity sedimentation gradients and restimulated in secondary MLC with 
X-irradiated CBA/J spleen cells. After secondary MLC, the activated lympho- 
cytes were tested in CML against various target cells. Identical culture condi- 
tions were used throughout except that B10.BR activation was performed in the 
presence of homologous serum while CBA/H activation was performed in cul- 
tures containing FBS. Results are presented in Table I. B10.BR anti-CBA/J cells 
failed to elicit detectable killing of CBA/J target cells regardless of the effector 
to target cell ratios examined. To control for the cytotoxic capacity of B10.BR 
cells per se,  an anti-H-2  reaction-B10.BR  anti-C57BL/10-was  included and 
showed positive  CML.  In  contrast  to  the  negative  CML  activity on  CBA/J 
targets by cells activated in mouse serum, the CBA/H anti-CBA/J cells lysed 
CBA/J targets, as well as CBA/H (i.e., self) and B10.BR cells. These reactions 
required only 4:1  effector to  target  cell ratios  for strong  CML.  No  cytolysis 
occurred against B10.S(7R) targets, which carry the H-2 th haplotype. 
Several  variations,  including restimulation  of primed  CBA/H  anti-CBA/J 
blasts in secondary MLC with CBA/H cells in place of CBA/J cells, proved just 
as  efficient in  producing  anti-H-2 k  CTLs  (Table  I).  Target  cell  destruction 
occurred against  CBA/H,  B10.BR,  and  CBA/J-strains  possessing  the H-2 ~ 
haplotype. Little or no killing occurred against B10.S(7R). 
Anti-Self-H-2  CTLs:  Dependence  on FBS  for  their Generation,  but  not for 
Subsequent Activity,  It is possible that FBS induces generation of anti-self-H- 
2-reactive T cells through the introduction of new antigens onto the surface of 
growing cells in vitro, a  situation somewhat analogous to the virus-infected or 
hapten-modified cell systems of anti-"self' reactivity (1-8).  To test this, purified 
splenic B10.BR anti-CBA/J T blast cells, generated in primary MLC containing 
FBS and then restimulated in secondary MLC with CBA/J spleen cells for 48 h, 
were tested for CML activity on various target cells generated either in medium 
supplemented with FBS  or in  serum-free medium. Target cells generated in 
serum-free medium should lack the possible FBS-induced antigens. Results of 
two such experiments are presented in Table II. B10.BR and CBA/J target cells 
were lysed by B10.BR anti-CBA/J CTLs irrespective of whether the target cells 
were generated in the presence or absence of FBS. Note, however, that nonsti- 
mulated, fresh B10.BR cells were not lysed, suggesting that target antigens do 
not develop during the 4 h  of the assay despite the presence of FBS. Thus, the 
CTLs apparently do not require recognition of FBS-induced target antigens to 
kill target cells. 
Also presented in Table  II are data consistent with the concept that FBS- 
dependent anti-self-H-2 cytolysis is determined by the SD regions of H-2. The H- 
2k-restricted nature of the CML activity is demonstrated in the positive killing 
of  target cells carrying the H-2 k haplotype, e.g., CBA/J and B10.BR. In addition, 
B10.BR  anti-CBA/J  CTLs  elicit strong killing against B10.RIII(71NS)  target 
cells (H-2r), reflecting the strong cross-reactivity of H-2 r and H-2 k observed in 810  RESPONSES  OF  T  LYMPHOCYTES  TO  NON-H-2  ALLOANTIGENS 
TABLE  I 
Anti-Self-H-2  Restricted Cytolytic Activity of T  Lymphocytes  against Mls Locus 
Product(s)  in Medium  Containing Heterologous  Serum 
Secondary  Effec- 
Serum source for  MLC-stim- 
Effector cells*  I ° and II  ° MLC  ulating  Target cell  tor:target  CML 
cell ratios 
cells 
B10.BR anti-CBA/J$  Mouse serum  CBA/J 
% 
CBA/J§  100:1  0.5 
CBA/J  50:1  -2.8 
CBA/J  25:1  -2.1 
CBA/J  12:1  -2.8 
CBA/J  6:1  0.3 
B10.BR anti-C57BL/10  Mouse serum  C57BL/10  C57BL/10  6:1  48.8 
CBA/H anti-CBA/J  FBS  CBA/J  CBA/J  4:1  23.4 
B10.BR  4:1  21.5 
CBA/H  4:1  29.3 
B10.S(7R)  4:1  0.0 
CBA/H  CBA/H  4:1  34.9 
B10.BR  4:1  32.3 
CBA/J  4:1  16.8 
B10.S(7R)  4:1  5.2 
* Effector cells collected 48 h  after secondary MLC activation. 
$ Genetic designations for strains in this table:  B10.BR  -  H-2 ~, Mlsb; B10.S(7R)  -  H-2 '~, MlsO; 
CBA/H  -  H-2 ~', Mlsb; CBA/J  -  H-2  ~', Mls'l; C57BL/10  -  H-2 b, Mls  b. 
§ Spontaneous release averaged between 24 and 34% of the maximum  release. 
allogeneic CML (28). This cross-reactivity is believed due to specificity H-2.25. 
We  also  observe  a  slight,  but  consistent  cross-reactivity of H-2  s  and H-2 k, 
another cross-reacting combination in allogeneic CML (28, 29). This is reflected 
in  the  CML  observed against  A.TL  cells  (possessing  haplotype H-2 tt  whose 
derivation is skkkkd), and to a lesser degree against B10.S(7R) cells (whose H- 
2 th haplotype derivation is sssssd). In the case of A.TL, both the H-2 1 and H-2 S 
regions are derived from H-2  k, yet the CML activity remains well within the 
range of H-2  k and H-2" cross-reactive responses (28). Thus, these data, although 
limited by the availability of proper genetic strains, suggest that the H-2 K  and 
H-2 D  region products exert the strongest influence on the development of H-2- 
restricted CML. 
Appearance of H-2.Restricted CTLs in Nonstimulated Cultures after Incuba- 
tion in Heterologous Serum.  No evidence exists for an anti-Mls locus antigen 
cytolytic reactivity in vitro. It is thus possible that MLC activation against the 
Mls locus products merely serves a catalytic helper function for development of 
anti-self-H-2 T-cell cytotoxicity. No requirement at all may exist for Mls locus 
activation: FBS per se might be able to induce anti-self-H-2 CTL development, 
especially in light of the recent demonstration that nonspecific killer cells can be 
induced by FBS (30). 
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TABLE  II 
Anti-Self-H-2  CML of Specific Target Cells Generated  in Serum-Free Medium or in 
Medium Supplemented  with Heterologous  Serum 
Secondary  Serum source  Effec- 
MLC-stim-  tor:tar- 
Exp.  Effector cells*  ulating  Target cells$  in culturestarget  cell  get cell  CML 
cells  ratios 
1  BI0.BR anti-CBA/J§  CBA/J 
2  BI0.BR anti-CBA/J  CBA/J 
% 
B10.BR  FBS  17:1  16.1 
CBA/J  FBS  17:1  32.0 
CBA/J  Serum-free  17:1  29.8 
B10.RIII(71NS)  FBS  17:1  22.5 
B10.BR  FBS  11:1  39.4 
B10.BR  Serum-free  lhl  58.5 
CBA/J  FBS  11:1  65.6 
CBA/J  Serum-free  11:1  47.6 
A.TL  FBS  11:1  11.3 
B10.S(7R)  FBS  11:1  4.7 
Fresh B10.BR  -  11:1  0.8 
* Effector cells collected from secondary MLC after 48 h of restimulation by CBA/J cells. 
LPS-stimulated 48 h before CML assay. 
§ Genetic  designations  for strains in this table: A.TL  -  H-2"  (skkkkd),  Mls"; B10.BR -  H-2  ~ 
(kkkhkk), MlsO; B10.RIII(71NS) -  H~2 r (rrrrrr),  Mlsb; B10.S(7R) -  H-2  'h (sssssd),  Mls  b CBA/J - 
H-2  ~" (kkkkkk), Mls  '~. 
2.5% FBS.  This serum concentration induces a  minor T-cell blast response and 
after 5 days in culture 42  x  10  e blast cells from an original population of 400  × 
10  e T  cells were collected. These blast cells were "restimulated" for 48 h  with X- 
irradiated  syngeneic  spleen  cells  in  secondary  MLC.  The  cultures  were  har- 
vested and tested for cytotoxicity on various target cells. Results are presented 
in Table III. Positive CML was observed on target cells possessing the "Bell'-H- 
2 k haplotype, i,e., B10.BR and CBA/J. No killing occurred against B10,S(7R) or 
A.TL targets,  two  strains  not  possessing H-2 k  haplotype-derived H-2  SD  re- 
gions.  Again,  CBA/J target cells generated in serum-free cultures  were sensi- 
tive to cytolysis. 
A  similar pattern of CML is exhibited by "FBS-activated" T cells when tested 
on a panel of TNP-conjugated target cells (Table III): only target cells possessing 
H-2  SD regions derived from the H-2 k haplotype were killed. TNP conjugation, 
therefore, does not prevent the anti-self-H-2 CTLs from recognizing and killing 
on the appropriate target antigen(s). 
Because  all  CML  assays  in  this  study  have  been  carried  out  in  medium 
supplemented with FBS, it remained possible that target cells, including those 
generated in serum-free medium, could be modified by FBS during the 4 h of the 
CML  assay,  thereby rendering  them  sensitive  to  cytolysis.  To eliminate  this 
possibility  we  have  examined  H-2-restricted  cytolysis in  a  totally  serum-free 
CML,  as well.  CBA/H effector cells were generated in nonstimulated  primary 
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TABLE  HI 
Generation of CTLs Exhibiting Anti-Self-H-2 CML after Incubation in Nonstimulated 
Cultures Supplemented with Heterologous Serum 
Effector  Secondary  Serum source in  Effec- 
Exp.  cells*  MLC-stimu-  Target cells$  target cell cul-  tor:target  CML 
lating cells  tures  cell ratios 
% 
1  B10.BR§  B10.BR  B10.BR  FBS  10:1  18.4 
CBA/J  FBS  10:1  9.6 
B10.S  FBS  10:1  -11.1 
2  B10.BR  B10.BR  B10.BR  FBS  25:1  20.3 
CBA/J  FBS  50:1  25.7 
25:1  24.9 
12:1  17.8 
6:1  15.2 
B10.BR 
CBA/J  Serum-free  25:1  19.4 
A.TL  FBS  25:1  -0.9 
B10.S(7R)  FBS  25:1  -3.1 
B10.BR-TNI~I  FBS  25:1  21.6 
CBA/J-TNP  FBS  25:1  28.7 
CBA/J-TNP  Serum-free  25:1  20.5 
A.TL-TNP  FBS  25:1  -0.9 
B10.S(7R)  FBS  25:1  0.2 
* Effector cells generated in nonstimulated primary culture supplemented with 2.5% FBS. Blast 
cells isolated on day 5 and "stimulated" with X-irradiated syngeneic B10.BR cells for 48 h. 
$ LPS-stimulated 48 h  before CML assay. 
§ Genetic designations for strains in this table: A.TL  -  H-2 r~  (skkkkd), Mls"; B10.BR  -  H-2 ~ 
(kkkkkk), Mlsb; B10.S  -  H-2" (ssssss),  Mlsb; B10.S(TR)  -  H-2 rh (sssssd),  Mlsb; CBA/J  -  H-2 ~' 
(kkkkkk), Mls". 
H  Target cells conjugated with TNP according to the procedures of Shearer (6). 
restimulation in secondary MLC with CBA/J cells, these blasts were tested for 
their  ability to  kill  LPS-stimulated targets  generated  either  in  serum-free 
medium or medium supplemented with mouse serum. The effector cells as well 
as the target cells were washed extensively in serum-free medium before CML 
assay.  Results of one experiment are  presented in Table  IV.  In general, the 
CBA/H CTLs elicited the same H-2k-restricted cytolysis as seen throughout this 
study-CBA/H, CBA/J, and B10.BR cells were killed to variable degrees, while 
B10.S(7R)  cells were not. Target cells generated in both serum-free medium or 
medium supplemented with mouse serum were lysed. CML in serum-free me- 
dium, as expected, is less than reactions observed in CML run in the presence of 
serum (Table IV). A type of interaction between FBS and mouse serum compo- 
nents or activity is suggested by the limited reactivity seen in the control CML 
against CBA/J target cells generated in mouse serum. Nevertheless, cytolysis of 
target cells never exposed to FBS make it highly improbable that the target 
antigens are induced by FBS per se. 
Discussion 
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TABLE  IV 
Anti-Self-H-2-Restricted Cytotoxicity  in a CML Assay Using Serum-Free Medium 
Effector  Secondary  Serum source in  Serum  source in 
cells*  MLC-stimu-  Target cells*  target cell cultures  CML  CML§ 
lating cells 
CBA/H  H  CBA/J  CBA/H  Mouse serum  Serum-free  3.7 
CBA/J  Mouse serum  Serum-free  15.7 
B10.BR  Mouse serum  Serum-free  12.3 
B10.S(7R)  Mouse serum  Serum-free  -7.8 
CBA/H  Serum-free  Serum-flee  9.3 
CBA/J  Serum-free  Serum-free  11.8 
B10.BR  Serum-flee  Serum-flee  6.3 
CBA/J  Mouse serum  FBS  5.5 
C BA/J  Serum-free  FBS  28.8 
* Effector cells generated in nonstimulated primary culture supplemented with 2.5% FBS. Blast 
cells were isolated on day 5 and stimulated with X-irradiated CBA/J spleen cells for 48 h. 
* LPS-stimulated 48 h  before CML assay. 
§ Effector: target cell ratio, 20:1. 
[I  Genetic designation of strains in this table: B10.BR -  H-2 ~', Mlsb; B10.S(7R) -  H-2  ~h, Mlsb; CBA/ 
H  -  H-2  ~', Mlsb; CBA/J  -  H-2  k, Mls". 
importance  of non-H-2  alloantigens  in  initiation  and  restimulation  of T-cell- 
mediated  cytotoxicity.  Recent reports  (9-11)  have  shown that  lymphoid cells 
presensitized  in  vivo against  non-H-2  alloantigens  develop anti-"self'-H-2-re- 
stricted cytotoxic reactivity which is demonstrable in vitro, thus analogous with 
the "self'-H-2-restricted  cytolysis against  virus-infected  (1-5) and  chemically- 
modified  (6-8) cells.  In each of these systems the sensitizing  and  subsequent 
target  cells  must  share  H-2  K  or D  region-associated  (SD)  specificities  for 
cytolysis to be effected. 
To facilitate the study of this phenomenon we have chosen a  completely in 
vitro model utilizing mouse strain combinations which possess identity at the H- 
2  locus, but which have genetic differences at non-H-2 loci that result in MLC 
activation  (i.e.,  the Mls  locus).  This  eliminates  the  requirement  for  in  vivo 
sensitization, which no doubt involves a variety of direct and indirect activation 
mechanisms. In addition, we have utilized three relatively simple procedures to 
insure that the major part of the observed reactivity is due to T lymphocytes: (a) 
Ig-anti-Ig-coated  glass  bead  column  separation  (18)  of the  primary  MLC-re- 
sponding cells which provides an initial responding population containing >98% 
T and <0.5% B cells, (b) 1 g  velocity sedimentation gradient separation (19, 20) 
of antigen-reactive  T  blast cells from nonresponding  cells,  and  (c)  secondary 
mixed  cultures  (20,  31,  32)  which  greatly  enhance  the  sensitivity of in vitro 
responses. In this way we have selected for highly purified, antigen-activated T- 
lymphocyte  populations  with  specific  responsiveness  against  the  sensitizing 
antigen(s). 
It  is  clear  from  the  results  of this  study  that  such  isolated  T-cell  clones, 
presumably activated by non-H-2 alloantigens residing on the stimulating cells, 
react in two distinct ways. First, they can exhibit a reactivity which we refer to 
as  specific  anti-Mls  (or  non-H-2)  alloantigen  responsiveness.  This  reaction 
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as primary and secondary stimulating populations.  Second, the isolated T-cell 
clones can exhibit a  specific anti-self-H-2-restricted reactivity in which the Mls 
locus difference apparently is irrelevant and in which there is no requirement 
for a  known genetic difference between stimulating  and responding cells (fur- 
ther discussion of specificity follows). 
This  dichotomy of T-cell  reactivity  is  controlled  completely by the  culture 
environment used during the primary-activation phase. Anti-Mls locus-specific 
T  cells  appear  to  be the  only T  population  activated  in  cultures  containing 
homologous mouse serum. In contrast, the dominating reactivity of T-cell blasts 
from cultures supplemented with a heterologous serum like FBS is anti-self-H- 
2-restricted in nature.  These data seriously question certain aspects of earlier 
work on H-2-restricted cytolysis and force a re-examination of such basic points 
as  (a)  the  nature  of the  antigen(s)  recognized  by  T  cells  in  anti-self-H-2- 
restricted vs. specific anti-non-H-2 reactions, (b) the factors which induce devel- 
opment of anti-self-H-2 reactions,  (c) the level at which an apparently specific 
anti-non-H-2 reaction is lost in favor of an anti-self-H-2-restricted response,  (d) 
whether  or  not  the  same  T-cell  clones  are  involved  in  these  two  types  of 
activities, and (e) the degree to which H-2-restricted cytotoxicity can represent a 
type of culture artifact, especially when adequate controls are lacking. Unfortu- 
nately, only part of these questions can be answered at this time. 
We have shown in Fig. 1 (the secondary MLC responses of B10.BR anti-CBA/ 
J) that T-cell clones generated in cultures supplemented with homologous serum 
exhibit  a  highly  discriminatory  reactivity  with  respect  to  restimulation  by 
relevant and irrelevant antigens.  MLC activation of B10.BR lymphocytes with 
CBA/J cells results primarily  from different allelic products at the Mls locus, 
therefore, the specific nature of the secondary reaction indicates development of 
specific memory in vitro to the Mls locus products per se.  We have found,  in 
addition, that H-2 identity between the primary and secondary stimulating cells 
is required for successful recognition of the specific Mls locus product. 3 Despite 
this,  it  must  be  pointed  out  that  such  memory T  cells  remain  incapable  of 
effecting target cell destruction against Mls locus antigens or against "self-H-2- 
associated" products (see Table I). 
In complete contrast,  T  lymphocytes activated by Mls locus alloantigens  in 
primary cultures supplemented with FBS, or even T  lymphocytes merely cul- 
tured with FBS, exhibit strong anti-self-H-2  reactivity, both MLC and  CML, 
with  no significant  specificity for the  priming  Mls  locus antigens.  It is most 
probable that FBS induces a  set of T-cell clones distinct from those specifically 
activated by Mls locus determinants.  The mechanism underlying the ability of 
FBS  to  activate  a  set  of T  cells  into  anti-self-H-2  reactivity  is  intriguing, 
especially in light of the recent report by Shustik et al.  (30) which shows that 
spleen  cells  incubated  in  FBS may develop a  totally  nonspecific,  yet strong, 
cytotoxic  capability.  Furthermore,  it  has  been  reported  (33)  that  FBS  can 
"induce" new antigenic  determinants  on cells growing in vitro,  making them 
susceptible to  immune  lysis.  But  perhaps  the  most  perplexing  aspect  is  the 
3 Peck, A. B., C. A. Janeway, Jr., and H. Wigzell. T lymphocyte  responses to Mls locus antigens 
involve  recognition  of H-2 I region  gene products. Manuscript submitted for publication. AMMON  B.  PECK,  LEIF  C.  ANDERSSON,  AND  HANS  WIGZELL  815 
requirement for fresh syngeneic cells to obtain restimulation of the blast cells 
(Fig. 2); cells within the culture itself appear incapable of stimulating. 
Antigen-activated T  cells  generated  in  the  presence  of FBS  display  H-2- 
restricted reactivity in both MLC and CML. The H-2-restricted MLC activation 
could be shown to be controlled by H-2 1 region determinants with no apparent 
activity against H-2 SD region determinants. On the other hand, H-2-restricted 
CTL  development could  be  shown  to  be  controlled by "self'-H-2  SD  region 
structures with no detectable effect from "self'-H-2 1 region components. This 
dichotomy of reactivity is similar to that observed in allogeneic T-cell-mediated 
cytotoxic reactions (22, 25, 26, 29). Also, the cross-killing of target cells in anti- 
self-H-2 CML reactions within this study, although limited to the H-2 k haplo- 
type, are identical with those reported for allogeneic CML (28). 
The altered-self  hypothesis (3, 7, 9) proposes to explain H-2-restricted cytolysis 
as a  response to surface component modification resulting from an interaction 
between a  modifying principle and H-2 SD determinants. Arguments against 
the idea that FBS acts primarily as a modifying agent at the level of secondary 
activation in this system stem from experiments in Fig.  3 and Tables II-IV. 
First, no evidence was obtained suggesting that in H-2-restricted reactions FBS 
or FBS-induced determinants must be present on secondary MLC-activating 
cells  or  CML  target  cells.  Anti-self-H-2  CML  occurred with  equal  vigor  on 
relevant target cells irrespective of whether the target cells were generated in 
serum-free medium or medium supplemented with FBS. Second, possible trans- 
fer of FBS or FBS-induced determinants by responding T  cells to target cells 
seem quite improbable since the effector cells would have to carry saturating 
amounts of "FBS-modified structures" and transfer them to target cells during 
the short assay time (4 h). Rather, the target cells per se must already express 
the antigenic structures which function as relevant antigen in H-2-restricted 
cytotoxic reactions. 
Although the H-2-restricted MLC and CML activity exhibit H-2/-associated 
and H-2 SD-associated restrictions, respectively, antigenic specificities distinct 
from H-2 antigens, as well as distinct from FBS components, cannot be ruled 
out. For example, target cells were for the most part LPS-stimulated spleen cells 
since Mls locus determinants are expressed on B and not T cells (34), and thus 
LPS antigen most likely is present on target cells. However, LPS antigen alone 
does not activate T cells directly and would thus seem an unlikely CML target 
antigen.  Likewise, Mls locus antigens or other non-H-2 alloantigens show no 
correlation with T-cell killing. More plausible antigens not so easily dismissed 
include various B-cell antigens like MBLA (35), MSplLA (36), Ia (37), Ala-1 (38), 
and Ly-8 (39) which can be recognized by T cells, including syngeneic T cells, or 
virus-associated determinants coded for by endogenous viruses which are acti- 
vated during cell transformations (40-42). 
It is clear from the above reasoning that it is important to delineate possible 
limitations for the types of target cells which function in anti-self-H-2 reactions. 
We suspect that the effector T cells and the subsequent target cells do possess 
some differences with respect to their surface structures. It is known that CTLs 
themselves are susceptible  to  cytolytic attack  (43); consequently,  should the 
anti-self-H-2-restricted CTL react against pure "self'-H-2 structures, then one 816  RESPONSES  OF  T  LYMPHOCYTES  TO  NON-H-2  ALLOANTIGENS 
might expect a totally suicidal CML reaction.  On the other hand, results of this 
study and others (30) force us to entertain the prospect that "self'-H-2 antigens 
may function just as efficiently as allogeneic H-2 antigens in controlling devel- 
opment of T-cell-mediated cytotoxic reactions. 
In conclusion, we have presented data indicating how highly specific anti-self- 
H-2  reactivity  against  both  H-2  I  region  determinants  and  H-2  SD  region 
structures  can  be  induced  in  vitro  merely  by  activating  T  lymphocytes  in 
cultures containing  heterologous serum.  These findings impose strict require- 
ments for adequate controls in studies of"conventional" anti-self-H-2-restricted 
immune reactions carried out in vitro. On the other hand,  they may provide us 
with some insight as to how T-cell-mediated autoimmune reactions may evolve. 
Summary 
The role of non-H-2 alloantigens, specifically Mls locus products, in secondary 
in vitro T-ceU-mediated cytotoxicity has been studied.  Splenic T lymphocytes, 
activated against Mls locus alloantigens in primary-mixed cultures and isolated 
by velocity  sedimentation  gradient  separation  techniques,  were  used  as  re- 
sponding populations in secondary mixed leukocyte cultures  (MLCs) and cell- 
mediated  lympholysis  (CML).  Such  T-cell  clones  could be  shown  to  exhibit 
either "self'-H-2-restricted or anti-Mls locus-specific reactivity, with this dichot- 
omy of reactivity depending only on the primary culture conditions. Mls locus- 
activated T lymphocytes generated in cultures supplemented with homologous 
serum exhibited specific memory responses in MLC, yet remained incapable of 
effecting target cell destruction against Mls locus antigens or against "self'-H-2 
structures in CML. In contrast, activated T-cell clones generated in the presence 
of heterologous  serum  displayed H-2-restricted  reactivity  in  both  secondary 
MLC and CML. H-2-restricted MLC activation was controlled by H-2 1 region 
products, whereas H-2-restricted CML activity was controlled by products of the 
H-2 serologically defined regions. Although heterologous serum was a necessary 
(and  sufficient)  entity  for  development  of H-2-restricted  responses,  evidence 
argues against the possibility that heterologous serum acts via modification of 
cell surface components. 
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